LinkedIn video ad examples

Your variant interpretation pipeline is strong. But can it reason? Deriva.ai is the first autonomous AI agent for variant analysis that plugs into existing software — reading papers, reasoning through ACMG criteria, explaining every call in real time. Your software. Our reasoning engine. Unbeatable combination. Let's partner — we'll help you beat the competition. Book a Meeting

#ACMG2026 ? Growing test volume shouldn't mean growing headcount... Deriva.ai is the first autonomous AI agent for variant analysis that scales with your sequencer — not your hiring plan. Same team. 10x the throughput. Check live video demo → Get First Access

Ben jij benieuwd hoe het is om op onze afdeling Verloskunde te werken? Kom gezellig langs! Drink een kop koffie met collega’s, kijk mee op de afdeling en ontdek hoe we met elkaar werken en voor elkaar klaarstaan. We ontmoeten je graag!

When we think of infant formula, we usually focus on what’s in it – protein, fats, vitamins… but new research is focusing on how these ingredients are being absorbed. So, we asked Gabriël Thomassen, Digestion & Absorption Scientist at Danone Research & Innovation, why it matters. Here’s what he said: “Human milk isn’t just a bunch of ingredients put together… it’s an intricate, living system! What if the structure of each nutrient was as important as the components themselves?” Inspired by the complexity of human milk, researchers from Danone R&I and Lyon University collaborated to create a model of infant digestion and then compared human milk to: a standard infant formula, an infant formula with added milk fat globule membrane (MFGM), and the Nuturis® concept formula, which contains larger phospholipid‑coated lipid droplets. “We found that larger droplets enriched with phospholipids get broken down very differently than the smaller, simpler droplets in standard formulas. This, in turn, influences how fats are digested and how energy and nutrients become available to our little ones,” Gabriel explains. These new insights open new paths for advancing nutrition solutions that better support infant growth and development. “We know that lab models can’t fully capture the complexity of the infant gut, but what matters to us is that this research provides a strong foundation for future clinical research linking nutrient structure to health outcomes,” Gabriel concludes. Want to know more about the publication? https://lnkd.in/dqy5qNyA #DanoneResearch #DanoneRnI #NutritionScience #Innovation #NUTURIS

Clinical research doesn’t happen without patients. That’s why we start by meeting them where they are.

Clinical research doesn’t happen without patients. That’s why we start by meeting them where they are, bringing research closer to their communities.

Dr. Skinner's team at Shoreview is staying fully booked AND leaving by 5 PM every day using Digitail. Grab a time on our calendar today. Your future self and your staff will thank you.

DeepUnity Adaptive Imaging: Die Zukunft der radiologischen Bildgebung Was wäre, wenn Ihre Systeme nicht nur funktionieren, sondern mitdenken, priorisieren und sich dynamisch anpassen? Mit DeepUnity Adaptive Imaging wird genau das Realität: KI, nahtlos integriert in Ihre radiologischen Workflows. ✅ Ergebnisse direkt im Viewer – ohne Systemwechsel ✅ KI-gestützte Worklists mit intelligenter Priorisierung ✅ Zugriff auf zahlreiche KI-Anwendungen für unterschiedliche Use Cases ✅ Automatische Zusammenfassung von Patientendaten ✅ Validierte KI-Ergebnisse direkt in Ihre Befunde integrierbar Ob Visualisierung, Workflow-Steuerung oder Befundung: Alle Komponenten greifen nahtlos ineinander und schaffen eine zentrale Plattform für moderne Radiologie. 👉Erfahren Sie mehr zu DeepUnity Adaptive Imaging im Video. #DeepUnity #Radiology #AI #MedicalImaging #DedalusDACHRegion

Not all beneficial microbes need to be alive to make an impact. As we celebrate this year’s World Microbiome Day, we’re shining a spotlight on the microscopic marvel earning a reputation as the ‘guardian of your gut.’ In this video, Gokul S., Director Biotics New Growth Spaces at Danone Research & Innovation, walks through the remarkable science behind Akkermansia muciniphila MucT. Present in more than 90% of healthy adults, this unique microbe has been found to have close ties to gut and metabolic health. MucT naturally resides in the gut’s mucus layer—the body’s first line of defense. Through specialized surface structures and bioactive proteins, it helps maintain gut integrity and supports overall health. What sets MucT apart is that its benefits extend beyond the live bacterium itself, making it a standout example of innovation in the postbiotics space. Check out the video to meet this marvelous microbe, and learn why it continues to capture the attention of microbiome researchers worldwide. Don’t miss our recent publication and article for a deeper dive into the science behind Akkermansia muciniphila MucT, alongside our Senior Director of Gut, Immune & Microbiology Jan Knol and Akkermansia pioneer Willem M. De Vos: https://lnkd.in/dh8p9uGE

Julie ne se reconnaissait plus dans ce qu'elle faisait. Épuisée, sans énergie, avec une boule au ventre chaque matin. Ce qui l'a poussée à changer ? L'envie d'un impact humain, concret, quotidien. Aujourd'hui, elle accompagne ses clientes vers le mieux-être. Elle les voit changer, retrouver confiance, retrouver le sourire. "Voir ce bonheur dans leurs yeux, c'est génial. Ça n'a pas de prix." Un métier aligné avec ses valeurs. Une autonomie totale. Un réseau qui ne la laisse jamais seule. 👉 Et si c'était votre prochain chapitre ?

A big thank you to the organizers of #ESHG2026 for another fantastic meeting in Gothenburg! We had an incredible few days filled with inspiring discussions, valuable insights from across the genetics community, and countless conversations at our booth and throughout the congress. It was a pleasure to reconnect with colleagues, partners, and customers, while also meeting many new faces. These opportunities to exchange ideas, learn from one another, and discuss the future of genetic testing are what make events like ESHG so special. Thank you to everyone who stopped by to talk with us. After three full days we left Gothenburg energized, inspired, and looking forward to continuing the conversations. Until next time! #ESHG2026 #HumanGenetics #GeneticTesting #MolecularDiagnostics

SOMETHING IS MOVING IN ALLERGY DIAGNOSTICS. At DIESSE, we already support laboratories with high-quality singleplex testing, in a fully automated monotest format - delivering reliable, targeted answers every day. But what if complexity could be decoded more efficiently? In 3 months, DIESSE will introduce a new macroarray approach to explore inhalant allergies - combining multiple insights in a single test. A new way to decode allergy is coming. 👉 Be among the first to discover it: https://lnkd.in/dxViD98k

𝗧𝗵𝗲 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗩𝗮𝗹𝘂𝗲 𝗼𝗳 𝗘𝗦𝗥, 𝗔𝘂𝘁𝗼𝗺𝗮𝘁𝗲𝗱 | 𝗕𝗼𝗼𝘁𝗵 #𝟮𝟮𝟳𝟱 The Erythrocyte Sedimentation Rate (ESR) remains one of the most widely ordered inflammatory markers in medicine. • Rheumatologic diseases • Chronic inflammation • Infection monitoring • Autoimmune disorders Not because it's traditional—but because it delivers critical, systemic clinical information that newer, single-protein markers cannot replace on their own. At DIESSE, we have spent 40 years perfecting ESR automation to make this essential test safer, faster, and completely waste-free. 📍 See our ESR ecosystem in person at Booth #2275 | ADLM 2026, Anaheim.

#Sponsored Our partner, Rakesh Jain, MD, MPH, explores how psychedelics like LSD are thought to induce neuroplasticity, the brain’s ability to adapt. This potential for adaptive change may help address unmet patient need in the mental health space. Explore the science of Rerouting Minds.

#Sponsored Rakesh Jain, MD, MPH, explores the "psychedelic renaissance,” in which treatments like pharmaceutical LSD are re-emerging with rigorous research. Clinicians must objectively evaluate this investigational compound’s potential to expand our patient toolkit. Explore this full-circle moment through Rerouting Minds.

Is TGCT/PVNS still just a surgical disease? Improving symptoms, functional status and quality of life are key in the management of this type of sarcoma. #SarcomaAwarenessMonth #TGCT #PatientSupport #QualityOfLife #RareDisease

Nearly half of patients with TGCT/PVNS experience misdiagnosis, missing out on specialist expertise that may influence management decisions. #SarcomaAwarenessMonth #TGCT #PatientSupport #QualityOfLife #RareDisease

At DePuy Synthes, we move the people who move us. Built on a legacy of orthopaedic leadership, our ongoing commitment to innovation has produced one of the world’s most comprehensive orthopaedic portfolios, enabling people to return to the moments that matter most. We remain focused on delivering care for the body that is felt most in the heart. Welcome to the Humanly moved era of DePuy Synthes. Learn more here: https://ow.ly/P8eB50ZnOoF

The growth of GLP‑1 therapies highlights how quickly formulation expectations are evolving. As peptide-based and biologic therapies advance, developers are looking for approaches that support stability, consistency and scalable performance. High-quality excipients play an important role in enabling this. With BioHale®, DFE Pharma combines excipient quality, advanced purification and European manufacturing expertise to support demanding applications. Trough our INTO - Inhalation Together partnership, we have developed in-vitro and in-vivo data using Trehalose, which supports the development of GLP formulations. Enabling formulation approaches designed for where biologics are heading next.

Even more in biologics than any other formulation, excipients shape performance, manufacturability, and patient access. Their strategic impact becomes clear when embedded in platform technologies that enable new therapies and address unmet needs. As a result, excipient selection becomes an integral part of development strategy. With BioHale®, DFE Pharma supports formulation approaches designed for today’s biologics requirements. Because strong formulations are built on more than active ingredients alone.

HCPs need trustworthy medicines information, on demand. Pharma need real-time insight to close content gaps. SRD search delivers both, accessible 24/7 on trusted platforms. Join Ian Hamilton (Datapharm) and Christian El-Khouri (Rote Liste) on 8th September to find out how.

“Je moet hier de mens achter het delict willen zien.” Dat maakt dit werk zo bijzonder volgens Christine.

“Je kijkt hier verder dan alleen de zorgvraag.” Dat maakt het werk voor Bart uitdagend en menselijk.

Planning to market your at-home test for wellness? Before you commit to that launch plan, understand how FDA’s general wellness policy may apply to your product. DCN Dx’s Wellness Regulatory Assessment is led by Dan Simpson, RAC, our Director of Regulatory Affairs. Dan reviews your product’s intended use, claims, collection or sensing method, and how results are presented to users. You receive a written assessment explaining how the policy may apply, the likely regulatory implications, and whether and how to contact FDA. The fixed fee is $6,900, with delivery in two to four weeks from kickoff and receipt of the materials needed for review. The assessment is DCN Dx’s professional opinion, not an FDA determination, clearance, or approval. Start with a 30-minute call to discuss your product and whether the assessment fits your needs. Learn more and request a call: dcndx.com/wellness #Diagnostics #RegulatoryAffairs